Identification of circulating tumor cells: A prognostic marker in squamous cell carcinoma of the head and neck?

Future Oncology

Volumn 7, Issue 4, 2011, Pages 481-484

  Jatana, Kris R ^a,b   Lang, Jas C ^a   Chalmers, Jeffrey J ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c Ohio State University   (United States)

Author keywords

circulating tumor cell; immunocytochemistry; immunomagnetic cell separation; squamous cell carcinoma of the head and neck

Indexed keywords

DISTANT METASTASIS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953715178     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.11.19     Document Type: Review

References (38)

1. Franceschi D, Gupta R, Spiro RH, Shah JP: Improved survival in the treatment of squamous carcinoma of the oral tongue. Am. J. Surg. 166(4), 360-365 (1993). (Pubitemid 24240988)
2. Zarbo RJ, Crissman JD: The surgical pathology of head and neck cancer. Semin. Oncol. 15(1), 10-19 (1988). (Pubitemid 18073027)
3. Gath HJ, Brakenhoff RH: Minimal residual disease in head and neck cancer. Cancer Metastasis Rev. 18(1), 109-126 (1999). (Pubitemid 29411096)
4. McGuirt WF Jr, Johnson JT, Myers EN, Rothfeld R, Wagner R: Floor of mouth carcinoma. The management of the clinically negative neck. Arch. Otolaryngol. Head Neck Surg. 121(3), 278-282 (1995).
5. Yuen AP, Wei WI, Wong YM, Tang KC: Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 19(7), 583-588 (1997). (Pubitemid 27407312)
6. Jones AS, Roland NJ, Field JK, Phillips DE: The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primar y sites. Clin. Otolaryngol. Allied Sci. 19(1), 63-69 (1994). (Pubitemid 24081618)
7. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB: Regional lymph node involvement and its signifcance in the development of distant metastases in head and neck carcinoma. Cancer 71(2), 452-456 (1993). (Pubitemid 23021234)
8. Snow GB, Annyas AA, van Slooten EA, Bartelink H, Hart AA: Prognostic factors of neck node metastasis. Clin. Otolaryngol. Allied Sci. 7(3), 185-192 (1982). (Pubitemid 12088842)
9. Braun S, Vogl FD, Naume B et al.: A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 353(8), 793-802 (2005). (Pubitemid 41215488)
10. Pantel K, Izbicki J, Passlick B et al.: Frequency and prognost ic signifcance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347(9002), 649-653 (1996). (Pubitemid 26076131)
11. Kasimir-Bauer S, Schleucher N, Weber R, Neu mann R, Seeber S: Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival. Oncol. Rep. 10(2), 475-482 (2003).
12. Kollermann J, Weikert S, Schostak M et al.: Prognostic signifcance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment. J. Clin. Oncol. 26(30), 4928-4933 (2008).
13. Leinung S, Wurl P, Schonfelder A, Weiss CL, Roder I, Schonfelder M: Detection of cytokeratin-positive cells in bone marrow in breast cancer and colorectal carcinoma in comparison with other factors of prognosis. J. Hematother. Stem Cell Res. 9(6), 905-911 (2000). (Pubitemid 32110291)
14. McKenzie SB: Textbook of Hematology. Williams and Wilkens, Inc., MD, USA (1996).
15. Wirtschafter A, Benninger MS, Moss TJ, Umiel T, Blazoff K, Worsham MJ: Micrometastatic tumor detection in patients with head and neck cancer: a preliminary report. Arch. Otolaryngol. Head Neck Surg 128(1), 40-43 (2002). (Pubitemid 34052082)
16. Toyoshima T, Vairaktaris E, Nkenke E, Schlegel KA, Neukam FW, Ries J: Hematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: preliminary results. Anticancer Res. 29(1), 291-297 (2009).
17. Ramani P, Thomas G, Ahmed S: Use of Rt-PCR in detecting disseminated cancer cells after incisional biopsy among oral squamous cell carcinoma patients. J. Cancer Res. Ther. 1(2), 92-97 (2005). (Pubitemid 41265235)
18. Dyavanagoudar S, Kale A, Bhat K, Hallikerimath S: Reverse transcriptase polymerase chain reaction study to evaluate dissemination of cancer cells into circulation after incision biopsy in oral squamo us cell carcinoma. Indian J. Dent. Res. 19(4), 315-319 (2008).
19. Stathopoulou A, Ntoulia M, Perraki M et al.: A highly specifc real-time RT-PCR method for the quantitative determination of CK-19 mRNA posi tive cells in peripheral blood of patients with operable breast cancer. Int. J. Cancer 119(7), 1654-1659 (2006). (Pubitemid 44258772)
20. Pinzani P, Mazzini C, Salvianti F et al.: Tyrosinase mRNA levels in the blood of uve al melanoma patients: correlation with the number of circulating tumor cells and tumor progression. Melanoma Res. 20(4), 303-310 (2010).
21. Arenberger P, Arenbergerova M, Vohradnikova O, Kremen J: Early detection of melanoma progression by quantitative real-time RT-PCR analysis for multiple melanoma markers. Keio J. Med. 57(1), 57-64 (2008). (Pubitemid 351744047)
22. Gkalpakiotis S, Arenberger P, Kremen J, Arenbergerova M: Quantitative detection of melanoma-associated antigens by multimarker real-time RT-PCR for molecular staging: results of a 5 years study Exp. Dermatol. 19(11), 994-999 (2010).
23. Koyanagi K, O'Day SJ, Boasberg P et al.: Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma. Clin. Cancer Res. 16(8), 2402-2408 (2010).
24. Vona G, Sabile A, Louha M et al.: Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulat ingtumor cells. Am. J. Pathol. 156(1), 57-63 (2000). (Pubitemid 30644439)
25. De Giorgi V, Pinzani P, Salvianti F et al.: Application of a fltration-and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma. J. Invest. Dermatol. 130(10), 2440-2447 (2010).
26. Cristofanilli M, Budd GT, Ellis MJ et al.: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351(8), 781-791 (2004). (Pubitemid 39095313)
27. Riethdorf S, Fritsche H, Muller V et al.: Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation stu dy of the CellSearch system. Clin. Cancer Res. 13(3), 920-928 (2007). (Pubitemid 46340368)
28. Stott SL, Hsu CH, Tsukrov DI et al.: Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad. Sci. USA 107(43), 18392-18397 (2010).
29. Sieuwerts AM, Kraan J, Bolt J et al.: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J. Natl Cancer Inst. 101(1), 61-66 (2009).
30. Berx G, Raspe E, Christofori G, Thiery JP, Sleeman JP: Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin. Exp. Metastasis 24(8), 587-597 (2007). (Pubitemid 50000849)
31. Chaffer CL, Thompson EW, Williams ED: Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 185(1-3), 7-19 (2007). (Pubitemid 46956838)
32. Mani SA, Guo W, Liao MJ et al.: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4), 704-715 (2008). (Pubitemid 351636299)
33. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J: Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 68(4), 989-997 (2008). (Pubitemid 351272216)
34. Yang J, Mani SA, Donaher JL et al.: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7), 927-939 (2004). (Pubitemid 38798858)
35. Yang L, Lang JC, B alasubramanian P et al.: Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol. Bioeng 102(2), 521-534 (2009).
36. Balasubramanian P, Yang L, Lang JC et al.: Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells. Mol. Pharm. 6(5), 1402-1408 (2009).
37. Partridge M, Brakenhoff R, Phillips E, et al.: Detection of rare disseminated tumor cells identifes head and neck cancer patients at risk of treatment failure. Clin. Cancer Res. 9 (14) 5287-5294 (2003). (Pubitemid 37413581)
38. Jatana KR, Balasubramanian P, Lang JC, et al.: Signifcance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results. Arch. Otolaryngol. Head Neck Surg. 136(12) 1274-1279 (2010).